<br />
<b>Warning</b>:  ini_set(): A session is active. You cannot change the session module's ini settings at this time in <b>/home/updatepublishing/public_html/journal/lib/pkp/classes/session/SessionManager.inc.php</b> on line <b>69</b><br />
<br />
<b>Warning</b>:  Cannot modify header information - headers already sent by (output started at /home/updatepublishing/public_html/journal/lib/pkp/classes/session/SessionManager.inc.php:69) in <b>/home/updatepublishing/public_html/journal/plugins/generic/citationStyleLanguage/CitationStyleLanguagePlugin.inc.php</b> on line <b>478</b><br />
<br />
<b>Warning</b>:  Cannot modify header information - headers already sent by (output started at /home/updatepublishing/public_html/journal/lib/pkp/classes/session/SessionManager.inc.php:69) in <b>/home/updatepublishing/public_html/journal/plugins/generic/citationStyleLanguage/CitationStyleLanguagePlugin.inc.php</b> on line <b>479</b><br />
TY  - JOUR
AU  - Sonali, S. Gadge
AU  - Vikrant, L. Salode
AU  - Madhuri, D. Game
PY  - 2021/03/13
Y2  - 2025/09/23
TI  - Drug repurposing in the treatment of COVID-19: A review
JF  - Research in Pharmacy
JA  - RIP
VL  - 11
IS  - 0
SE  - Articles
DO  - 10.25081/rip.2021.v11.6611
UR  - https://www.updatepublishing.com/journal/index.php/rip/article/view/6611
SP  - 1-7
AB  - &lt;p style=&quot;text-align: justify;&quot;&gt;The first outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was in Wuhan, Hubei, China in December 2019 and declared as a pandemic by the World Health Organization. Currently, there is no proven effective vaccine or therapeutic agent to combat the deadly coronavirus disease. Currently, prevention from the infection, control measures and supportive care help to treat against COVID-19. Until an effective vaccine is available for COVID-19 infection, one can repurpose known therapeutic agents that block the entry of the virus into the host cell and control the COVID-19 infection. Drug repurposing is the new use of old drugs. In this review, the most common and possible drug treatment for COVID-19 is highlighted. The therapeutic agents include antiviral drugs like Remdesivir, chloroquine, hydroxychloroquine, lopinavir/ritonavir, umifenovir, favipiravir and oseltamivir and other agents. Clinical trials are ongoing to evaluate the safety and efficacy of these therapeutic agents in COVID-19 patients.&lt;/p&gt;
ER  -